The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Hormonal Predictors of Prostate Cancer: A Meta-Analysis
Abstract
PURPOSE: Although there is strong circumstantial evidence that androgens are implicated in the etiology of prostate cancer, epidemiologic investigations have failed to demonstrate consistently that one or more steroid hormones are implicated. In contrast, recent epidemiologic studies unequivocally link serum insulin-like growth factor 1 (IGF-1) levels with risk for prostate cancer. METHODS: We have performed the first meta-analysis of all previously published studies on hormonal predictors of risk for prostate cancer. RESULTS: A meta-analysis restricted to studies that performed mutual adjustment for all measured serum hormones, age, and body mass index indicated that men whose total testosterone is in the highest quartile are 2.34 times more likely to develop prostate cancer (95% confidence interval, 1.30 to 4.20). In contrast, levels of dihydrotestosterone and estradiol do not seem to play a role of equal importance. The only study that provides multivariably adjusted sex hormone–binding globulin data indicates that this binding protein is inversely related to prostate cancer risk (odds ratio, 0.46; 95% confidence interval, 0.24 to 0.89). Finally, all three studies that examined the role of serum IGF-1 have consistently demonstrated a positive and significant association with prostate cancer risk that is similar in magnitude to that of testosterone. CONCLUSION: Men with either serum testosterone or IGF-1 levels in upper quartile of the population distribution have an approximately two-fold higher risk for developing prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study
Chan, J. M., Stampfer, M. J., Giovannucci, E., Gann, P. H., Ma, J., Wilkinson, P., Hennekens, C. H., & Pollak, M. (1998) · Science · doi:10.1126/science.279.5350.563 · Cited by 1,996
Prospective Study of Sex Hormone Levels and Risk of Prostate Cancer
Gann, P. H., Hennekens, C. H., Ma, J., Longcope, C., & Stampfer, M. J. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1118 · Cited by 782
Endogenous hormones as a major factor in human cancer.
Henderson, B. E., Ross, R. K., Pike, M. C., & Casagrande, J. T. (1982) · PubMed · Cited by 602
Insulin-Like Growth Factor 1 and Prostate Cancer Risk: A Population-Based, Case-Control Study
Wolk, A., Mantzoros, C. S., Andersson, S.-O., Bergstrom, R., Signorello, L. B., Lagiou, P., Adami, H.-O., & Trichopoulos, D. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.12.911 · Cited by 575
Self-citation5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males
Ross, R. K., Bernstein, L., Pike, M. C., Henderson, B. E., Lobo, R. A., Stanczyk, F. Z., & Shimizu, H. (1992) · The Lancet · doi:10.1016/0140-6736(92)90927-u · Cited by 495
Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
Mantzoros, C., Tzonou, A., Signorello, L., Stampfer, M., Trichopoulos, D., & Adami, H.-O. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.520 · Cited by 366
Self-citationCOHEN, P., PEEHL, D. M., LAMSON, G., & ROSENFELD, R. G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-73-2-401 · Cited by 355
Prostate Cancer: A Current Perspective
Nomura, A. M. Y., & Kolonel, L. N. (1991) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036069 · Cited by 301
The Intranuclear Metabolism of Testosterone in the Accessory Organs of Reproduction
WILSON, J. D., & GLOYNA, R. E. (1970) · Proceedings of the 1969 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571126-5.50012-1 · Cited by 249
Burfeind, P., Chernicky, C. L., Rininsland, F., Ilan, J., & Ilan, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.14.7263 · Cited by 238
Pietrzkowski, Z. J., Mulholland, G., Gomella, L. G., Jameson, B. A., Wernicke, D., & Baserga, R. (1993) · PubMed · Cited by 236
Comparative Rates of Androgen Production and Metabolism in Caucasian and Chinese Subjects
Santner, S. J., Albertson, B., Zhang, G.-Y., Zhang, G., Santulli, M., Wang, C., Demers, L. M., Shackleton, C. H. L., & Santen, R. J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.6.4898 · Cited by 180
Angelloz-Nicoud, P. (1995) · Endocrinology · doi:10.1210/en.136.12.5485 · Cited by 167
A prospective, population-based study of androstenedione, estrogens, and prostatic cancer.
Barrett-Connor, E. L., Garland, C. F., McPhillips, J. B., Khaw, K., & WINGARD, D. L. (1990) · PubMed · Cited by 156
Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.
Hsing, A. W., & Comstock, G. W. (1993) · PubMed · Cited by 134
Prediagnostic serum hormones and the risk of prostate cancer.
Nomura, A. M. Y., Heilbrun, L. K., Stemmermann, G. N., & Judd, H. L. (1988) · PubMed · Cited by 129
Kimura, G., Kasuya, J., Giannini, S., Honda, Y., Mohan, S., Kawachi, M. H., Akimoto, M., & Fujita‐Yamaguchi, Y. (1996) · International Journal of Urology · doi:10.1111/j.1442-2042.1996.tb00628.x · Cited by 117
Comparative Rates of Androgen Production and Metabolism in Caucasian and Chinese Subjects
Santner, S. J. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.6.2104 · Cited by 112
Harper, M. E., Peeling, W. B., Cowley, T., Brownsey, B. G., Phillips, M. E., Groom, G. V., Fahmy, D. R., & Griffiths, K. (1976) · European Journal of Endocrinology · doi:10.1530/acta.0.0810409 · Cited by 109
Familial Prostatic Cancer Risk and Low Testosterone*
Meikle, A. W., & Stanish, W. M. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-6-1104 · Cited by 98
BARTSCH, W., Horst, H.-J., Becker, H., & Nehse, G. (1977) · European Journal of Endocrinology · doi:10.1530/acta.0.0850650 · Cited by 98
SERUM STEROIDS IN NORMAL MALES AND PATIENTS WITH PROSTATIC DISEASES
Hammond, G. L., Kontturi, M. J., Vihko, P., & Vihko, R. (1978) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1978.tb02189.x · Cited by 94
Montie, J. E., & Pienta, K. J. (1994) · Urology · doi:10.1016/0090-4295(94)90163-5 · Cited by 94
Serum androgens and prostate cancer.
Nomura, A. M. Y., Stemmermann, G. N., Chyou, P.-H., Henderson, B. E., & Stanczyk, F. Z. (1996) · PubMed · Cited by 91
Čulig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G. C., & Klocker, H. (1995) · European Urology · doi:10.1159/000475232 · Cited by 88
Zumoff, B., Levin, J., Strain, G. W., Rosenfeld, R. S., O'Connor, J., Freed, S. Z., Kream, J., Whitmore, W. S., Fukushima, D. K., & HELLMAN, L. (1982) · The Prostate · doi:10.1002/pros.2990030607 · Cited by 75
Rannikko, S., & Adlercreutz, H. (1983) · The Prostate · doi:10.1002/pros.2990040302 · Cited by 66
Jackson, M. A., Kovi, J., Heshmat, M. Y., et al. (1980) · The Prostate · doi:10.1002/pros.2990010205 · Cited by 66
Andersson, S.-O., Adami, H., Bergström, R., & WIDE, L. E. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.293 · Cited by 60
5 alpha-reductase activity and prostate cancer: a case-control study using stored sera.
Guess, H. A., FRIEDMAN, G. D., Sadler, M., Stanczyk, F. Z., Vogelman∥, J. H., Imperato‐McGinley, J., Lobo, R., & Orentreich∥, N. (1997) · PubMed · Cited by 59
Hormones and Prostate Cancer: Where Do We Go From Here?
Hsing, A. W. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.16.1093 · Cited by 55
Gustafsson, O., Norming, U., Gustafsson, S. A., Eneroth, P. H. E., Åström, G., & Nyman, C. R. (1996) · British Journal of Urology · doi:10.1046/j.1464-410x.1996.89120.x · Cited by 44
Comstock, G. W., Gordon, G., & Hsing, A. W. (1993) · PubMed · Cited by 40
Hulka, B. S., Checkoway, H., Hammond, J. E., DiFerdinando, G. T., Mickey, D. D., Fried, F. A., Stumpf, W. E., Beckman, W. C., & Clark, T. D. (1987) · The Prostate · doi:10.1002/pros.2990110208 · Cited by 38
Effect of diet on plasma and urinary hormones in South African black men with prostatic cancer.
Hill, P., Wynder, E. L., Garbaczewski, L., & Walker, A. R. P. (1982) · PubMed · Cited by 37
Production, clearance, and metabolism of testosterone in men with prostatic cancer
Meikle, A. W., Smith, J. A., & Stringham, J. D. (1987) · The Prostate · doi:10.1002/pros.2990100106 · Cited by 36
Estradiol and testosterone metabolism and production in men with prostatic cancer
Meikle, A. W., Smith, J. A., & Stringham, J. D. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90352-x · Cited by 21
Blood hormone levels related to stages and grades of prostatic cancer
Høisaeter, P. A., Haukaas, S. A., Bakke, Å., Höiem, L., Segadal, E., & Thorsen, T. (1982) · The Prostate · doi:10.1002/pros.2990030407 · Cited by 13
Cited by
Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline.
Bhasin, S., Brito, J. P., Cunningham, G. R., Hayes, F. J., Hodis, H. N., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., Wu, F. C., & Yialamas, M. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00229 · Cited by 1,736
Obesity and cancer risk: Emerging biological mechanisms and perspectives
Avgerinos, K. I., Spyrou, N., Mantzoros, C. S., & Dalamaga, M. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.001 · Cited by 1,567
Self-citationEndogenous Sex Hormones and Prostate Cancer: A Collaborative Analysis of 18 Prospective Studies
Hormones, E. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djm323 · Cited by 786
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Kasper, J. S., & Giovannucci, E. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0410 · Cited by 491
Does sexual dimorphism in human faces signal health?
Rhodes, G., Chan, J., Zebrowitz, L. A., & Simmons, L. W. (2003) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rsbl.2003.0023 · Cited by 404
Metadata
- Authors
- Shaneyfelt, T., Husein, R., Bubley, G., & Mantzoros, C. S.
- Venue
- Journal of Clinical Oncology
- Published
- 2000-02-14
- Volume
- 18
- Issue
- 4
- Pages
- 847-847
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W1888935883
- Cited by
- 310
- References
- 39
- FWCI
- 5.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.